Our Guidelines Rundown Series continues with a new article focusing on multiple sclerosis (MS). Currently, there are limited guidelines available on MS, all of which are provided by the American Academy of Neurology. These guidelines encompass a range of topics including vaccines and immunizations, therapies, alternative medicine, as well as the assessment and management of psychiatric disorders in individuals with MS. Let’s now explore the list of clinical practice guidelines on MS:

Guidelines From American Academy of Neurology (AAN)

  • Disease-Modifying Therapies For Adults With Multiple Sclerosis
    • Publication: April 01, 2018
    • Objective: To review evidence on starting, switching, and stopping disease-modifying therapies (DMTs) for multiple sclerosis (MS) in people with clinically isolated syndrome (CIS), relapsing/remitting MS (RRMS), and progressive forms of MS; and to develop recommendations for starting, switching, and stopping DMTs.

Thank you for reviewing the current MS guidelines. If there are any that we may have overlooked, please do not hesitate to inform us. Additionally, we welcome suggestions for future topics to cover in our Guidelines Rundown Series. Sign up for alerts and stay informed on the latest published guidelines and articles. Stay tuned for our next installment!

Copyright © 2024 Guideline Central, All rights reserved.